Colorectal Cancer Alliance Partners with Amgen to Drive Research Progress

Michael Sapienza, Chief Executive Officer of the Colorectal Cancer Alliance, recently attended the Amgen Advocacy Summit. The event brought together advocacy leaders and Amgen leadership to share insights and collaborate on providing meaningful impact to patients.

The summit featured discussions, interactive sessions, and networking opportunities designed to strengthen partnerships that drive progress in cancer research.

Sapienza took this opportunity to share the cutting-edge work of the Colorectal Cancer Alliance through their Project Cure CRC initiative. This initiative aims to match patients with new treatments faster based on their biomarkers using the KLEOS adaptive clinical trial platform.

The CEO expressed gratitude towards partners like Amgen who help advance cutting-edge science and support advocacy efforts in the fight against colorectal cancer.